OncoSenX is a late stage pre-clinical cancer company targeting solid tumors using a unique Proteo-Lipid Vehicle and plasmid DNA to induce apoptosis in cancerous cells
OncoSenX is a late stage pre-clinical cancer company targeting solid tumors using a unique Proteo-Lipid Vehicle and plasmid DNA to induce apoptosis in cancerous cells.
OncoSenX is a late stage pre-clinical cancer company targeting solid tumors using a unique Proteo-Lipid Vehicle and plasmid DNA to induce apoptosis in cancerous cells
OncoSenX is a late stage pre-clinical cancer company targeting solid tumors using a unique Proteo-Lipid Vehicle and plasmid DNA to induce apoptosis in cancerous cells.